Live Breaking News & Updates on Prostate Cancer Foundation Scientific

Stay updated with breaking news from Prostate cancer foundation scientific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fortress Biotech Reports Record 2020 Financial Results and Recent Corporate Highlights


Our six dermatology products are marketed by our partner company, Journey Medical Corporation (“Journey”).
Our products generated net revenues of $44.5 million for full-year 2020, compared to full-year 2019 net revenues of $34.9 million, representing growth of 28%. Our products generated $13.7 million in revenues in the fourth quarter of 2020, compared to $11.1 million in the fourth quarter of 2019, representing growth of 23%. While we generated revenue growth year-over-year in 2020, sales of our products were impacted by the COVID-19 pandemic, which caused a temporary supply shortage and impacted the ability of our sales force to make in person calls, due to states slowly re-opening.
We in-licensed and recently launched our sixth prescription dermatology product. ....

United States , Fred Hutch , Samsung Biologics , Lindsaya Rosenwald , International Symposium On Amyloidosis , American Society Of Hematology Annual Meeting , Prostate Cancer Foundation Scientific , Trademark Office , Committee For Orphan Medicinal Products , European Society For Medical Oncology Virtual Congress , Health Technology Assessments , Madison Pharmaceuticals Inc , Caelum Biosciences Inc , Fred Hutchinson Cancer Research Center Hutch , Society For Immunotherapy Of Cancer , Checkpoint Therapeutics Inc , Jude Children Research Hospital , European Commission , Drug Administration , Journey Medical Corporation , Alexion Pharmaceuticals Inc , Mustang Bio Inc , Neupharma Inc , Zydus Group , European Medicines Agency , Fortress Biotech Inc ,